IPM.ai Reviews

IPM.ai Description

Specialty and Rare Diseases have undefined patient populations with individuals who may be undiagnosed or incorrectly diagnosed, healthcare providers unaware of disease states, manifestations and treatment journeys. IPM.ai is an Insights-as-a-Service (IaaS) company that empowers the world's leading life sciences brands to better understand and improve the lives of patients through the development, clinical study, and commercialization of therapeutic interventions. Forecast market size, competitive landscape and ROI potential to maximize commercialization efforts. Discover ideal patients who have been misdiagnosed or undiagnosed, and who may be suitable for disease intervention and therapeutic intervention. Model statistically the number of cases of disease present in a specific patient population at any given time. Identify physicians that diagnose and treat ideal patient and influence other healthcare providers.